Treatment of depression in type 2 diabetic patients: Effects on depressive symptoms, quality of life and metabolic control
Conclusions: Treating depressive symptoms with medical therapy in T2DM is associated with improvements in QoL and depression, but with no improvement in metabolic control or weight.
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Joana Nicolau, Rosmeri Rivera, Carla Francés, Begoña Chacártegui, Lluís Masmiquel Tags: Clinical Care and Education Source Type: research
More News: Celexa | Citalopram | Depression | Diabetes | Diabetes Type 2 | Education | Endocrinology | Pain | Study | Universities & Medical Training